Target intelligence / Profile preview

RNA, U6 small nuclear 128, pseudogene (RNU6-128P)

Target
RNU6-128P
Molecular classification
Other
01

Overview

**RNA, U6 small nuclear 128, pseudogene (RNU6-128P)** is a human pseudogene derived from the U6 small nuclear RNA gene family. U6 small nuclear RNA (snRNA) is a critical component of the spliceosome complex involved in the splicing of pre-messenger RNA, but RNU6-128P is classified as a pseudogene, meaning it is not expected to produce a functional RNA or protein product[1][4]. As a pseudogene, RNU6-128P does not have known biological function, disease association, or relevance as a therapeutic target. **Clarification:** - The “pseudogene” annotation means RNU6-128P is not an active gene and does not produce a functional snRNA component[1][4]. - It is not a receptor, enzyme, transporter, or other typical drug target class. - No evidence was found for biological or disease roles, drug interactions, or use as a biomarker. - U6 snRNA is essential for splicing and broadly expressed, but *this specific pseudogene* is non-functional and not a therapeutic target[1][3][4]. - There is nothing obviously misspelled about the identifier, but it is critical to note it is a pseudogene and *not* a valid therapeutic or biological target.

Other names
RNU6-128PRNA, U6 small nuclear 128, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 128, pseudogene (RNU6-128P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 128, pseudogene (RNU6-128P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call